TrialCardiovascular research2024
Inclisiran administration potently and durably lowers LDL-C over an extended-term follow-up: the ORION-8 trial.
R Scott Wright et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
48 papers cite it
this paperpooled ittrialcites it